Incite.org
VC Fund
Burlingame, United States
Incite.org is an organization started by Matt Rogers and Swati Mylavarapu to support new, world-improving ideas, leaders, and teams. Incite is comprised of three branches, each of which has its own area of focus:Incite Ventures, LLC supports mission-driven enterprise through investments in businesses with the potential to scale, inspire others,and make a difference.Incite Labs is a 501(c)(3) nonprofit organization that makes grants and program-related investments to further charitable, educational, and scientific purposes.Incite Politics is the name of the work of Incite’s founders, Swati Mylavarapu and Matt Rogers, to personally organize and support initiatives to pass legislation and elect candidates who approach our country’s issues from a fresh perspective.
- Total investments:
- 23
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Incite.org invests in
Stages Incite.org invests in
Countries Incite.org invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Software 6 (26%)
- Energy 3 (13%)
- Agriculture 3 (13%)
- Health Care 3 (13%)
- Sustainability 3 (13%)
Stage
- Seed 11 (48%)
- Series A 9 (39%)
- Pre-Seed 1 (4%)
- Series B 1 (4%)
- Venture - Series Unknown 1 (4%)
Country
- United States 21 (91%)
- Canada 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Matt Rogers
Founder
|
Founder | Total investments: 12 | Find email | |
Swati Mylavarapu
Managing Partner
|
Managing Partner | Total investments: 5 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Archimetis provides an AI-powered operational reasoning system for complex industrial facilities. The platform applies industrial AI and agent-based reasoning to help energy, chemical, pharma, and refinery operators predict failures and optimize processes in real time. Archimetis analyzes plant data from planning to execution to support faster,higher-confidence operational decisions. The system is designed for refineries and process manufacturing environments seeking to reduce downtime and improve throughput. Archimetis also offers demos and implementation support for refinery and process manufacturing teams. | $11.5M / Venture - Series Unknown / Feb 11, 2026 | ||
| Carba is a clean-energy firm that is creating a reactor that transforms carbon dioxide into charcoal. | $6M / Seed / Dec 03, 2025 | ||
| Curve Biosciences is a biotechnology company focused on enhancing chronic disease care through precision medicine. With a team led by experts such as Nathan Hunkapiller, PhD, as Chief Scientific Officer, and Chuba Oyolu, PhD, as Chief Technology Officer, the company is at the forefront of research and development in the biotech field. CurveBiosciences aims to leverage scientific advancements to provide targeted solutions for chronic diseases, emphasizing the importance of precision in treatment approaches. The company operates within the biotechnology industry and is dedicated to improving patient outcomes through innovative research. | $40M / Series A / Oct 29, 2025 | ||
| Replenysh is building the operating system of material recovery — using technology to put an end to landfills and ocean pollution. | $8M / Series A / Apr 29, 2025 | ||
| HomeBoost operates as a home energy platform. | $4M / Seed / Oct 29, 2024 | ||
| GALY develops biomaterials through biotechnology and synthetic biology in order to discover new ways to produce natural things. The company was founded in 2016 and is headquartered in Amherst, Massachusetts. | $33M / Series B / Sep 03, 2024 | ||
| Amulet is shining a light on invisible threats in our food system. Amulet has two core brands: - Allergy Amulet helps consumers determine whether their foods are safe by detecting potentially life-threatening allergenic ingredients. - Amulet Scientific equips businesses and manufacturers with tools to help ensure the safety of their food supplychain. Learn more: www.allergyamulet.com www.amuletscientific.com | $5.8M / Series A / Aug 12, 2024 | ||
| Allergy Amulet is the world’s smallest and fastest consumer food allergen sensor, testing for common allergenic ingredients in seconds. Whether it’s on a keychain, a necklace, a wristband, or in a pocket, Allergy Amulet’s sleek and portable design allows users to savor life’s important moments, safely and simply. Food allergies affect 32 millionAmericans and between 220-520 million people globally. That’s 1 in 13 children and 1 in 10 adults. Allergy Amulet has the potential to improve the quality of life for the millions of people living with food allergies or intolerances. | $5.8M / Series A / Aug 12, 2024 | ||
| Windfall Bio’s nature-based solution harnesses natural microbes known as mems to capture and transform waste methane from any source into valuable outputs, like fertilizer for organic farming, carbon credits, and progress toward sustainability goals. With Windfall technology, any methane-intensive industry—like oil & gas, agriculture, and wastemanagement—can operate more efficiently while improving profitability and environmental impact. Windfall’s solution makes sense for both small and large operations and high and low concentrations of methane and can be easily and rapidly scaled across the globe, providing a low-cost, low-maintenance way to transform methane emissions into real value. Founded in 2022 and based in San Mateo, CA, Windfall is venture-backed by top-tier firms including Amazon’s Climate Pledge Fund, B37 Ventures, Baruch Future Ventures, Bessemer Venture Partners, Breakthrough Energy Ventures, Cavallo Ventures, Global Brain (through its Norinchukin Innovation Fund L.P.), Incite Ventures, MCJ Collective, Mayfield, Positive Ventures, Prelude Ventures, and UNTITLED (a fund backed by the Tetra Laval family). To learn more about how Windfall is transforming methane from a costly liability into a powerful tool for efficiency and profitability, visit www.windfall.bio. | $28M / Series A / Apr 08, 2024 | ||
| Aigen is connecting farmers to breakthrough technologies, decarbonizing agriculture, and improving human and planetary health. The company is developing an autonomous, solar-powered robotics platform that manages plants without the chemical inputs that undermine soil's carbon storage potential by bringing alternatives to conventionalpractices, allowing farmers to regenerate soil health and deal with the global agriculture manual labor shortage. | $12M / Series A / Oct 12, 2023 | ||
| See all 23 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Incite.org invest in?
Incite.org invests primarily in Software, Energy and Agriculture startups, most often at Seed and Series A stage. Most of the 23 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Incite.org?
Public channels for Incite.org include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Incite.org?
The team at Incite.org includes Matt Rogers (Founder) and Swati Mylavarapu (Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
